| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |